Skip to main content

Hernia Mesh Lawsuits: Federal Judge Declines Dismissal

Hernia Mesh Lawsuits: Federal Judge Declines Dismissal

Hernia Mesh Lawsuits: Federal Judge Declines Dismissal

Introduction

Judge Peter G. Sheridan of the U.S. District Court for the District of New Jersey declined to dismiss product liability and personal injury claims involving Ethicon Inc.'s hernia mesh.

According to a lawsuit filed, the plaintiff from Texas received a mesh implant in 2011, to repair his inguinal hernia. The implant was removed in January 2017, as he experienced chronic abdominal pain and multiple infections. The lawsuit was filed in December 2018 against Ethicon in the U.S. District Court, District of New Jersey for negligence, strict product liability, breach of express and implied warranties, and violation of consumer protection laws.

Ethicon argued over the allegation and requested a dismissal stating that the lawsuit filed was too late. New Jersey imposes a two-year statute of limitations on personal injury and product liability claims, which begins running once a plaintiff knows or should have known the cause of his injuries. The plaintiff, however, maintained that the statute of limitations didn’t begin to run until his revision surgery in January 2017.

In an order published September 11, Judge Sheridan signified the defense could raise a motion only where it affirmatively appears on the face of the complaint that the action pleaded is barred by the statute of limitations.

All Ethicon hernia mesh lawsuits are consolidated under MDL No. 2327 (In Re: Ethicon Inc., Pelvic Repair System Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!